An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer
NCT01339832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2017-05-17
Summary
This observational study is a follow-up study of protocol ML18280. Survival data of patients who took part in and concluded study ML18280 will be collected for up to 5 years after LPLV of ML18270.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer
NCT00421824 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.
NCT00353262 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients
NCT00335595 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma
NCT00216424 ·Status: TERMINATED ·Phase: PHASE4
-
Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma
NCT00353457 ·Status: TERMINATED ·Phase: PHASE2
-
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
NCT00686166 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
NCT00202774 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.
NCT01227707 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
NCT00003704 ·Status: COMPLETED ·Phase: PHASE1
-
XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma
NCT00557713 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer
NCT00828672 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer
NCT00215982 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal Cancer
NCT00159432 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
NCT01664494 ·Status: COMPLETED
-
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
NCT00086931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
NCT00250835 ·Status: TERMINATED ·Phase: PHASE2
-
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
NCT00625183 ·Status: TERMINATED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer
NCT00766155 ·Status: COMPLETED ·Phase: PHASE3
-
Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer
NCT00383695 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
NCT00081224 ·Status: TERMINATED ·Phase: PHASE2
-
Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
NCT00189683 ·Status: UNKNOWN ·Phase: PHASE3
-
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
NCT00093379 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
NCT00048126 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer
NCT00048139 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer
NCT01489332 ·Status: UNKNOWN ·Phase: PHASE2